Ettinger DS - Search Results

1

Phase I and pharmacokinetic study of brequinar sodium (NSC 368390).

Noe DA, Rowinsky EK, Shen HS, Clarke BV, Grochow LB, McGuire WB, Hantel A, Adams DB, Abeloff MD, Ettinger DS, et al. Noe DA, et al. Among authors: ettinger ds. Cancer Res. 1990 Aug 1;50(15):4595-9. Cancer Res. 1990. PMID: 2369734

2

Phase I and pharmacokinetic study of hepsulfam (NSC 329680).

Hendricks CB, Grochow LB, Rowinsky EK, Forastiere AA, McGuire WP, Ettinger DS, Sartorius S, Lubejko B, Donehower RC. Hendricks CB, et al. Among authors: ettinger ds. Cancer Res. 1991 Nov 1;51(21):5781-5. Cancer Res. 1991. PMID: 1933848 Clinical Trial.

3

Phase II trial of menogaril as initial chemotherapy for metastatic breast cancer.

Kennedy MJ, Donehower RC, Grochow LB, Ettinger DS, Fetting JH, Abeloff MD. Kennedy MJ, et al. Among authors: ettinger ds. Invest New Drugs. 1990 Aug;8(3):289-94. doi: 10.1007/BF00171839. Invest New Drugs. 1990. PMID: 2148742 Clinical Trial.

4

Phase II study of n-methylformamide (NSC 3051) and spirogermanium (NSC 192965) in the treatment of advanced small cell lung cancer.

Ettinger DS, Finkelstein DM, Abeloff MD, Chang YC, Smith TJ, Oken MM, Ruckdeschel JC. Ettinger DS, et al. Invest New Drugs. 1990 May;8(2):183-5. doi: 10.1007/BF00177255. Invest New Drugs. 1990. PMID: 2166720 Clinical Trial.

5

Phase I study and pharmacodynamics of piroxantrone (NSC 349174), a new anthrapyrazole.

Hantel A, Donehower RC, Rowinsky EK, Vance E, Clarke BV, McGuire WP, Ettinger DS, Noe DA, Grochow LB. Hantel A, et al. Among authors: ettinger ds. Cancer Res. 1990 Jun 1;50(11):3284-8. Cancer Res. 1990. PMID: 2334921

6

Phase I and pharmacodynamic study of taxol in refractory acute leukemias.

Rowinsky EK, Burke PJ, Karp JE, Tucker RW, Ettinger DS, Donehower RC. Rowinsky EK, et al. Among authors: ettinger ds. Cancer Res. 1989 Aug 15;49(16):4640-7. Cancer Res. 1989. PMID: 2568175

7

Assessment of N-methylformamide (NMF) administered orally on a three times weekly schedule: a phase I study.

Rowinsky EK, Grochow LB, Hantel A, Ettinger DS, Vito BL, Donehower RC. Rowinsky EK, et al. Among authors: ettinger ds. Invest New Drugs. 1989 Nov;7(4):317-25. doi: 10.1007/BF00173761. Invest New Drugs. 1989. PMID: 2599802

8

A phase I trial of trimetrexate glucuronate (NSC 352122) given every 3 weeks: clinical pharmacology and pharmacodynamics.

Grochow LB, Noe DA, Ettinger DS, Donehower RC. Grochow LB, et al. Among authors: ettinger ds. Cancer Chemother Pharmacol. 1989;24(5):314-20. doi: 10.1007/BF00304765. Cancer Chemother Pharmacol. 1989. PMID: 2758561

9

Phase I trial of taxol in patients with advanced cancer.

Donehower RC, Rowinsky EK, Grochow LB, Longnecker SM, Ettinger DS. Donehower RC, et al. Among authors: ettinger ds. Cancer Treat Rep. 1987 Dec;71(12):1171-7. Cancer Treat Rep. 1987. PMID: 2891441

10

Phase I trial of trimetrexate glucuronate on a five-day bolus schedule: clinical pharmacology and pharmacodynamics.

Grochow LB, Noe DA, Dole GB, Rowinsky EK, Ettinger DS, Graham ML, McGuire WP, Donehower RC. Grochow LB, et al. Among authors: ettinger ds. J Natl Cancer Inst. 1989 Jan 18;81(2):124-30. doi: 10.1093/jnci/81.2.124. J Natl Cancer Inst. 1989. PMID: 2909752

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

319 results

Search Page

Filters